biosanteform8a.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
__________________
 
FORM 8-A/A


FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
 
__________________
 
 
BIOSANTE PHARMACEUTICALS, INC.
(Exact Name of registrant as specified in its charter)
 
Delaware
58-2301143
  
(State of incorporation or organization)
 
(I.R.S. Employer Identification Number)
  
111 Barclay Boulevard
Lincolnshire, Illinois
 
60069
(Address of principal executive offices)
(Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:
 
Title of each class
to be so registered
Name of each exchange on which
each class is to be registered
 
Common Stock, par value $0.0001
 
The NASDAQ Stock Market LLC

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box:   x
 
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box:   o
 
 
Securities Act registration statement file number to which this form relates:  Not applicable
 
Securities to be registered pursuant to Section 12(g) of the Act:  None

Item 1.  Description of Registrant’s Securities to Be Registered
 
The description of the registrant’s common stock, par value $0.0001 per share, is incorporated by reference to the material under the section “Description of Capital Stock” in the registrant's registration statement on Form SB-2 as filed with the Securities and Exchange Commission on September 5, 2003, as amended, Commission Reg. No. 333-108550.
 
Item 2.  Exhibits.
 
Exhibit No.
Description
3.1
Amended and Restated Certificate of Incorporation of BioSante Pharmaceuticals, Inc.
3.2
Amendment to Amended and Restated Certificate of Incorporation of BioSante Pharmaceuticals, Inc.
3.3
Bylaws of BioSante Pharmaceuticals, Inc.
   

SIGNATURE
 
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.
 
BIOSANTE PHARMACEUTICALS, INC.
 
By:   /s/Phillip B. Donenberg
    Phillip B. Donenberg
Chief Financial Officer, Treasurer and Secretary
Dated:  October 31, 2007
 


BIOSANTE PHARMACEUTICALS, INC.
 
REGISTRATION STATEMENT ON FORM 8-A/A
 
INDEX TO EXHIBITS
 

Exhibit No.
 
Description
 
Method of Filing
3.1
Amended and Restated Certificate of Incorporation of BioSante Pharmaceuticals, Inc.
Incorporated by reference to Exhibit 3.1 contained in BioSante’s Registration Statement on Form SB-2 (Reg. No. 333-64218)
3.2
Amendment to Amended and Restated Certificate of Incorporation of BioSante Pharmaceuticals, Inc.
Incorporated by reference to Exhibit 3.2 contained in BioSante’s Form 8-A
(File No. 001-31812)
3.3
Bylaws of BioSante Pharmaceuticals, Inc.
Incorporated by reference to Exhibit 3.2 contained in BioSante’s Registration Statement on Form SB-2 (Reg. No. 333-64218)